ARCHIVES

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

This article is from The Cancer Letter archive.

Vol. 11 No. 47 | December 6, 1985

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers

July 15, 2011

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Leukemia Society Accepting Grant Applications for ‘88

May 22, 1987

In Radio Address, Clinton Outlines Administration Priorities

October 2, 1998

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979